• LAST PRICE
    1.7300
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.5814%)
  • Bid / Lots
    1.6700/ 7
  • Ask / Lots
    1.7800/ 11
  • Open / Previous Close
    1.7600 / 1.7200
  • Day Range
    Low 1.6913
    High 1.7700
  • 52 Week Range
    Low 1.1300
    High 3.7775
  • Volume
    65,278
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.72
TimeVolumeCRDF
09:32 ET42651.77
09:37 ET40001.736
09:44 ET11001.745
09:46 ET4701.76
09:57 ET15001.7401
10:02 ET1501.7368
10:06 ET1001.7449
10:08 ET1001.7449
10:11 ET6551.725
10:15 ET6001.73
10:24 ET8751.75
10:26 ET5141.77
10:31 ET2711.7536
10:44 ET30001.73
10:56 ET26931.73
11:00 ET4001.73
11:02 ET1001.735
11:05 ET1001.74
11:38 ET1001.74
11:52 ET2411.71
11:56 ET20001.72
11:57 ET1411.7121
12:03 ET1001.725
12:06 ET51001.7201
12:15 ET1001.725
01:08 ET20001.725
01:11 ET2001.715
01:13 ET10001.73
01:15 ET3001.72
01:26 ET1001.72
01:31 ET10001.7299
01:40 ET4001.73
01:47 ET15001.72
01:51 ET6001.72
02:03 ET2001.72
02:12 ET10001.71
02:16 ET11001.7
02:18 ET3001.7
02:20 ET5671.695
02:21 ET5001.7
02:32 ET5001.705
02:38 ET1001.705
02:39 ET40501.705
02:41 ET72661.705
02:43 ET2001.7
03:12 ET8791.71
03:19 ET1001.7099
03:32 ET12701.705
03:33 ET5011.705
03:44 ET1751.7068
03:46 ET20001.71
03:50 ET1001.72
04:00 ET42531.73
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRDF
Cardiff Oncology Inc
76.8M
-1.9x
---
United StatesDBTX
Decibel Therapeutics Inc
77.9M
-1.3x
---
United StatesMBIO
Mustang Bio Inc
75.7M
-0.9x
---
United StatesHCWB
HCW Biologics Inc
75.3M
-5.8x
---
United StatesIOBT
IO Biotech Inc
80.1M
-1.1x
---
United StatesRZLT
Rezolute Inc
73.5M
-1.1x
---
As of 2023-01-26

Company Information

Cardiff Oncology Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatment for cancer patients. Its drug candidate onvansertib, is a polo-like kinase 1 (PLK1) adenosine triphosphate (ATP) competitive inhibitor with the combination of chemotherapy and targeted therapeutics. Its clinical trial includes TROV-054, CRDF-001 and TROV-053. TROV-054 is a Phase I b/2 open-label clinical trial of onvansertib in combination with FOLFIRI (folinic acid, fluorouracil, and irinotecan) and Avastin (bevacizumab). TROV-053 is a Phase II open-label clinical trial of onvansertib in combination with Zytiga (abiraterone acetate)/prednisone. CRDF-001 is a Phase 2 open-label multi-center clinical trial of onvansertib in combination with nanoliposomal irinotecan, leucovorin, and fluorouracil for second line treatment of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).

Contact Information

Headquarters
11055 Flintkote AveSAN DIEGO, CA, United States 92121-1220
Phone
858-952-7570
Fax
858-217-4768

Executives

Independent Chairman of the Board
Rodney Markin
Chief Executive Officer
Mark Erlander
Chief Financial Officer
James Levine
Chief Operating Officer
Vicki Kelemen
Independent Director
James Armitage

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$76.8M
Revenue (TTM)
$391.0K
Shares Outstanding
44.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.64
EPS
$-0.93
Book Value
$3.35
P/E Ratio
-1.9x
Price/Sales (TTM)
196.5
Price/Cash Flow (TTM)
---
Operating Margin
-10,239.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.